Autologous Hematopoietic Stem Cell Transplantation
11
1
1
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
1 terminated out of 11 trials
75.0%
-11.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (11)
Clinical Study on the Preservation of Ovarian Function Following Autologous Hematopoietic Stem Cell Transplantation Using Goserelin
Exercise in Patients Undergoing Autologous Stem Cell Transplantation: A Randomized Controlled Trial
Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma
Clinical Study of Improved BEAM Conditioning Regimen for ASCT in Lymphoma
Precision Dosing of Busulfan in Children Undergoing HSCT
IDA+BUCY vs BUCY Conditioning Regimen for Intermediate-risk AML Undergoing Auto-HSCT
Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT
BUCYE Conditioning Regimen for PCNSL Undergoing Auto-HSCT
BUCY+VP-16 vs BUCY Conditioning Regimen for DLBCL Undergoing Auto-HSCT
Exercise in Pediatric Autologous Stem Cell Transplant Patients
Prevention of Left Ventricular Dysfunction During Chemotherapy